Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry and Food and Drug Administration Staff-Class II Special Controls Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle, 67764 [2015-27970]

Download as PDF 67764 Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration Food and Drug Administration [Docket No. FDA–2012–N–0115] [Docket No. FDA–2014–N–2076] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry and Food and Drug Administration Staff—Class II Special Controls Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Survey on Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types [Docket No. FDA–2015–N–3921] AGENCY: Food and Drug Administration, AGENCY: Food and Drug Administration, HHS. ACTION: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Guidance for Industry and Food and Drug Administration Staff—Class II Special Controls Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: On June 29, 2015, the Agency submitted a proposed collection of information entitled ‘‘Guidance for Industry and Food and Drug Administration Staff— Class II Special Controls Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0594. The approval expires on September 30, 2018. A copy of the supporting statement for this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Notice of public webinar; request for comments. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Survey on Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: On August 18, 2015, the Agency submitted a proposed collection of information entitled ‘‘Survey on Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0744. The approval expires on September 30, 2018. A copy of the supporting statement for this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: October 28, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–27944 Filed 11–2–15; 8:45 am] BILLING CODE 4164–01–P Dated: October 28, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–27970 Filed 11–2–15; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 18:04 Nov 02, 2015 Jkt 238001 PO 00000 Food and Drug Administration, ACTION: Notice. SUMMARY: Notice. AGENCY: HHS. HHS. ACTION: Health Canada and United States Food and Drug Administration Joint Public Consultation on International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; Public Webinar; Request for Comments Frm 00067 Fmt 4703 Sfmt 4703 The Food and Drug Administration (FDA or Agency) is announcing a regional public webinar entitled ‘‘Health Canada and U.S. Food and Drug Administration Joint Public Consultation on International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).’’ The goal of this webinar is to provide information and receive comments on the ICH, as well as the upcoming ICH meetings in Jacksonville, FL, in December 2015. The topics to be discussed are the topics for discussion at the forthcoming ICH Management Steering Meeting. The purpose of the webinar is to solicit public input prior to the next Steering Committee and Expert Working Group meetings in Jacksonville, FL, scheduled for December 5 to 10, 2015, at which the discussion of the topics underway and ICH reforms will continue. DATES: The public webinar will be held on November 12, 2015, from 1 p.m. to 4 p.m., Eastern Standard Time. Registration to attend the webinar and requests for online presentations must be received by November 6, 2015. See the SUPPLEMENTARY INFORMATION section for information on how to register for the webinar. Interested persons may submit either electronic or written comments to the public docket (see ADDRESSES) by December 12, 2015. ADDRESSES: You may submit comments as follows: SUMMARY: Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your E:\FR\FM\03NON1.SGM 03NON1

Agencies

[Federal Register Volume 80, Number 212 (Tuesday, November 3, 2015)]
[Notices]
[Page 67764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-27970]



[[Page 67764]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0115]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Guidance for Industry and Food and 
Drug Administration Staff--Class II Special Controls Automated Blood 
Cell Separator Device Operating by Centrifugal or Filtration Separation 
Principle

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Guidance for Industry and Food and 
Drug Administration Staff--Class II Special Controls Automated Blood 
Cell Separator Device Operating by Centrifugal or Filtration Separation 
Principle'' has been approved by the Office of Management and Budget 
(OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On June 29, 2015, the Agency submitted a 
proposed collection of information entitled ``Guidance for Industry and 
Food and Drug Administration Staff--Class II Special Controls Automated 
Blood Cell Separator Device Operating by Centrifugal or Filtration 
Separation Principle'' to OMB for review and clearance under 44 U.S.C. 
3507. An Agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0594. 
The approval expires on September 30, 2018. A copy of the supporting 
statement for this information collection is available on the Internet 
at https://www.reginfo.gov/public/do/PRAMain.

    Dated: October 28, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-27970 Filed 11-2-15; 8:45 am]
 BILLING CODE 4164-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.